01 1Aurobindo Pharma Limited
01 1BREXPIPRAZOLE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-03-01
Pay. Date : 2019-02-11
DMF Number : 33572
Submission : 2019-02-13
Status : Active
Type : II
20
Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is BREXPIPRAZOLE, with a corresponding US DMF Number 33572.
Remarkably, this DMF maintains an Active status since its submission on February 13, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 01, 2019, and payment made on February 11, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
